Genetic Influence on LDL-Cholesterol Levels: Role of Polygenic Risk Scores and Lp(a) Beyond Monogenic Hypercholesterolemia
Genes · 21.06.2026 · 17 (6) · 721
DOI: 10.3390/genes17060721 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Genes, online erschienen am 21.06.2026. Verfasst von Martina Ferrandino und 6 weiteren Autor:innen. Beteiligte Einrichtung: Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università Degli Studi di Napoli Federico II, Via Pansini 5, 80131 Naples, Italy. Hauptthemen laut MEDLINE: Cholesterol, LDL, Lipoprotein(a), Hypercholesterolemia, Multifactorial Inheritance. Die Arbeit nennt 154 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
High levels of low-density lipoprotein cholesterol (LDL-c) have been recognized as the main causal factor of atherosclerotic cardiovascular disease (ASCVD) and are influenced by both genetic and environmental factors. Among genetic determinants, Familial Hypercholesterolemia (FH) is the most common monogenic disorder, caused by rare high-impact variants in genes involved in LDL uptake. Other monogenic causes of hypercholesterolemia include sitosterolemia, cerebrotendinous xanthomatosis and lysosomal acid lipase deficiency (LALD). However, monogenic disorders only account for a small proportion of inherited hypercholesterolemia. In many individuals, increased LDL-c levels are caused by the contemporary presence of different single-nucleotide polymorphisms (SNPs) with a moderate/low impact. These SNPs could be summarized through polygenic risk scores (PRS) that attribute relative weight to each of these. Another genetic determinant of hypercholesterolemic phenotypes is high levels of lipoprotein(a)—Lp(a). Lp(a) is an LDL particle modified by the binding of apolipoprotein(a)—apo(a)—which represents an independent risk factor for ASCVD. Lp(a) levels are mainly genetically determined by variation in the number of kringle IV type 2 (K-IV2) repeats, as well as by several SNPs, and remain stable throughout life. The aim of this narrative review is to report an updated overview of the genetic mechanisms underlying hypercholesterolemia, including monogenic disorders, PRS and Lp(a), focusing on their potential repercussion in clinical practice by the integration into cardiovascular risk stratification beyond traditional clinical assessment. This integration could lead to a more comprehensive and individualized approach to cardiovascular prevention, with emerging perspectives including the possible use of artificial intelligence (AI).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università Degli Studi di Napoli Federico II, Via Pansini 5, 80131 Naples, Italy.
- CEINGE Biotecnologie Avanzate Franco Salvatore, Via Gaetano Salvatore 486, 80145 Naples, Italy.
- Dipartimento di Medicina Clinica e Chirurgia, Università Degli Studi di Napoli Federico II, Via Pansini 5, 80131 Naples, Italy.
ORCID-Profile: Martina Ferrandino, Gabriella Iannuzzo, Ilenia Lorenza Calcaterra, Matteo Nicola Dario Di Minno, Maria Donata Di Taranto
Zitieren
APA
Ferrandino, M., Cerrato, Y., Iannuzzo, G., Calcaterra, I. L., Di Minno, M. N. D., Fortunato, G., & Di Taranto, M. D. (2026). Genetic Influence on LDL-Cholesterol Levels: Role of Polygenic Risk Scores and Lp(a) Beyond Monogenic Hypercholesterolemia. Genes, 17(6), 721. https://doi.org/10.3390/genes17060721
Vancouver
Ferrandino M, Cerrato Y, Iannuzzo G, Calcaterra IL, Di Minno MND, Fortunato G, et al. Genetic Influence on LDL-Cholesterol Levels: Role of Polygenic Risk Scores and Lp(a) Beyond Monogenic Hypercholesterolemia. Genes. 2026;17(6):721. doi:10.3390/genes17060721
BibTeX
@article{Ferrandino2026,
author = {Ferrandino, Martina and Cerrato, Ylenia and Iannuzzo, Gabriella and Calcaterra, Ilenia Lorenza and Di Minno, Matteo Nicola Dario and Fortunato, Giuliana and Di Taranto, Maria Donata},
title = {Genetic Influence on LDL-Cholesterol Levels: Role of Polygenic Risk Scores and Lp(a) Beyond Monogenic Hypercholesterolemia},
journal = {Genes},
year = {2026},
volume = {17},
number = {6},
pages = {721},
doi = {10.3390/genes17060721}
}
EUVIMED